InsiderTape plots every Form 4 on the price chart and flags cluster buys, CEO conviction, and first buys in years the moment they file. Start a free 7-day trial, cancel anytime.
START FREE TRIAL →Sukumar Nagendran, President and Head of R&D, is a corporate insider tracked by InsiderTape across 1 company. The public record shows 10 open-market SEC Form 4 transactions: 2 purchases worth $84K and 8 sales worth $5.2M, reported from Feb 2, 22 to Jul 10, 26. Over this period they have been a net seller.
| Date | Company | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Jul 10, 26 | TSHATaysha Gene Therapies, Inc. | SELL | 200.0K | $6.24 | $1.2M |
| Jan 26, 26 | TSHATaysha Gene Therapies, Inc. | SELL | 26.9K | $4.61 | $124K |
| Jan 23, 26 | TSHATaysha Gene Therapies, Inc. | SELL | 89.1K | $4.75 | $423K |
| Jan 12, 26 | TSHATaysha Gene Therapies, Inc. | SELL | 200.0K | $4.71 | $942K |
| Dec 1, 25 | TSHATaysha Gene Therapies, Inc. | SELL | 260.0K | $4.51 | $1.2M |
| Nov 28, 25 | TSHATaysha Gene Therapies, Inc. | SELL | 110.1K | $4.75 | $523K |
| Sep 10, 25 | TSHATaysha Gene Therapies, Inc. | SELL | 200.0K | $3.23 | $646K |
| Aug 21, 25 | TSHATaysha Gene Therapies, Inc. | SELL | 57.1K | $2.85 | $163K |
| May 16, 23 | TSHATaysha Gene Therapies, Inc. | BUY | 5.0K | $0.68 | $3K |
| Feb 2, 22 | TSHATaysha Gene Therapies, Inc. | BUY | 10.0K | $8.01 | $80K |